# FDA Inspection 984313 - South Nassau Communities Hospital - August 23, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/south-nassau-communities-hospital/b78ea02d-fa3f-4407-8029-593bb79c2ad2
Source feed: FDA_Inspections

> FDA Inspection 984313 for South Nassau Communities Hospital on August 23, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 984313
- Company Name: South Nassau Communities Hospital
- Inspection Date: 2016-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 974958 - 2016-06-29](https://www.globalkeysolutions.net/records/fda_inspections/south-nassau-communities-hospital/86d9947f-2e3c-4184-bfdd-25e0aabcdf54)
- [FDA Inspection 875482 - 2014-04-21](https://www.globalkeysolutions.net/records/fda_inspections/south-nassau-communities-hospital/dbbff998-e293-45d5-9e46-29ae54d20e46)
- [FDA Inspection 778439 - 2012-05-01](https://www.globalkeysolutions.net/records/fda_inspections/south-nassau-communities-hospital/b5de6ac0-03fd-4d8f-b7b3-7c14d755c8d2)
- [FDA Inspection 667716 - 2010-06-04](https://www.globalkeysolutions.net/records/fda_inspections/south-nassau-communities-hospital/de8c00f6-21c8-4219-9106-d08f5be53560)

Company: https://www.globalkeysolutions.net/companies/south-nassau-communities-hospital/167709ab-f0af-460d-b947-293c5a724ed3

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d